This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Aug 1;3(8):781-782.

doi: 10.1001/jamacardio.2018.1312.

Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply

Robert J Clarke¹, Theingi Aung¹, Jane Armitage¹

Affiliations

PMID: 29874365
DOI: 10.1001/jamacardio.2018.1312

Comment

Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply

Robert J Clarke et al. JAMA Cardiol. 2018.

. 2018 Aug 1;3(8):781-782.

doi: 10.1001/jamacardio.2018.1312.

Authors

Robert J Clarke¹, Theingi Aung¹, Jane Armitage¹

Affiliation

¹ Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, England.

PMID: 29874365
DOI: 10.1001/jamacardio.2018.1312

No abstract available

PubMed Disclaimer

Comment on

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, Chew EY, Bosch J, Collins R, Lewington S, Armitage J, Clarke R; Omega-3 Treatment Trialists’ Collaboration. Aung T, et al. JAMA Cardiol. 2018 Mar 1;3(3):225-234. doi: 10.1001/jamacardio.2017.5205. JAMA Cardiol. 2018. PMID: 29387889 Free PMC article.
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.
Nodari S, Butler J, Temporelli PL. Nodari S, et al. JAMA Cardiol. 2018 Aug 1;3(8):781. doi: 10.1001/jamacardio.2018.1309. JAMA Cardiol. 2018. PMID: 29874369 No abstract available.
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.
Cicero AFG, Fogacci F, Borghi C. Cicero AFG, et al. JAMA Cardiol. 2018 Aug 1;3(8):780-781. doi: 10.1001/jamacardio.2018.1306. JAMA Cardiol. 2018. PMID: 29874376 No abstract available.

Similar articles

Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.
Cicero AFG, Fogacci F, Borghi C. Cicero AFG, et al. JAMA Cardiol. 2018 Aug 1;3(8):780-781. doi: 10.1001/jamacardio.2018.1306. JAMA Cardiol. 2018. PMID: 29874376 No abstract available.
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.
Nodari S, Butler J, Temporelli PL. Nodari S, et al. JAMA Cardiol. 2018 Aug 1;3(8):781. doi: 10.1001/jamacardio.2018.1309. JAMA Cardiol. 2018. PMID: 29874369 No abstract available.
Rebuttal to Aung et al, "Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals".
von Schacky C. von Schacky C. Altern Ther Health Med. 2018 Mar;24(2):8-9. Altern Ther Health Med. 2018. PMID: 29859508
Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
Cao Y, Lu L, Liang J, Liu M, Li X, Sun R, Zheng Y, Zhang P. Cao Y, et al. Cell Biochem Biophys. 2015 May;72(1):77-81. doi: 10.1007/s12013-014-0407-5. Cell Biochem Biophys. 2015. PMID: 25427890 Review.
Omega-3 fatty acids and cardiovascular disease.
Jain AP, Aggarwal KK, Zhang PY. Jain AP, et al. Eur Rev Med Pharmacol Sci. 2015;19(3):441-5. Eur Rev Med Pharmacol Sci. 2015. PMID: 25720716 Review.

See all similar articles

Cited by

Effects of Different n6/n3 PUFAs Dietary Ratio on Cardiac Diabetic Neuropathy.
Urlić M, Urlić I, Urlić H, Mašek T, Benzon B, Vitlov Uljević M, Vukojević K, Filipović N. Urlić M, et al. Nutrients. 2020 Sep 10;12(9):2761. doi: 10.3390/nu12092761. Nutrients. 2020. PMID: 32927766 Free PMC article.
Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence.
Bassuk SS, Manson JE; VITAL Research Group. Bassuk SS, et al. Cardiovasc Res. 2023 Jun 13;119(6):1297-1309. doi: 10.1093/cvr/cvac172. Cardiovasc Res. 2023. PMID: 36378553 Free PMC article. Review.
Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
Manson JE, Bassuk SS, Cook NR, Lee IM, Mora S, Albert CM, Buring JE; VITAL Research Group. Manson JE, et al. Circ Res. 2020 Jan 3;126(1):112-128. doi: 10.1161/CIRCRESAHA.119.314541. Epub 2020 Jan 2. Circ Res. 2020. PMID: 31895658 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations